Yaxess is a bespoke market access consultancy to pharmaceutical, biotech and medical device clients. We offer strategic input and practical solutions to pricing and reimbursement challenges that companies face in order to fulfil health technology assessment criteria and to meet the requirements of decision makers in an increasingly demanding climate. Drawing on 25 years' experience in the industry and a network of leading experts in the field, we offer unique insight into the evolution of HTA assessment and Real-World Evidence. We work across the spectrum from primary care conditions to specialist commissioning and rare diseases. Our services include global dossier preparation, country-specific submissions, internal co-ordination of market access activities, qualitative and quantitative pricing research, competitor analysis and critical appraisal of historical market access approaches. Our deliverables range from internal reports to publications in peer-reviewed journals, from pricing submissions to local budget impact models, to meet both your needs and those of your customers. We help you not only to achieve a positive endorsement for your technologies but also to gain optimum product positioning to facilitate their uptake in the market. What sets us apart from others is our confidence to visit your customers, from intentional experts to local decision makers to ensure that the right message relates to their population.